Industry News
9/8/2017
Joe Raedle/Getty Images

The FDA issued a warning letter to Pfizer unit Meridian Medical Technologies, Mylan's EpiPen manufacturer, for regulatory violations related to product complaint resolution, design verification and quality control procedures. The letter said Meridian failed to address violations cited in a 2014 inspection, which include failing to deliver the intended amount of epinephrine.

Related Summaries